JFS Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.6K | Sell |
89
-11
| -11% | -$4.9K | ﹤0.01% | 512 |
|
|
2025
Q1 | $48.5K | Buy |
100
+1
| +1% | +$485 | ﹤0.01% | 481 |
|
|
2024
Q4 | $39.9K | Hold |
99
| – | – | ﹤0.01% | 503 |
|
|
2024
Q3 | $46K | Buy |
99
+2
| +2% | +$930 | ﹤0.01% | 485 |
|
|
2024
Q2 | $45.5K | Sell |
97
-1
| -1% | -$469 | ﹤0.01% | 433 |
|
|
2024
Q1 | $41K | Hold |
98
| – | – | ﹤0.01% | 468 |
|
|
2023
Q4 | $39.9K | Buy |
98
+10
| +11% | +$4.07K | ﹤0.01% | 444 |
|
|
2023
Q3 | $30.6K | Hold |
88
| – | – | ﹤0.01% | 447 |
|
|
2023
Q2 | $31K | Hold |
88
| – | – | ﹤0.01% | 446 |
|
|
2023
Q1 | $27.7K | Sell |
88
-10
| -10% | -$3.15K | ﹤0.01% | 469 |
|
|
2022
Q4 | $28.3K | Sell |
98
-11
| -10% | -$3.18K | ﹤0.01% | 461 |
|
|
2022
Q3 | $32K | Sell |
109
-116
| -52% | -$34.1K | ﹤0.01% | 468 |
|
|
2022
Q2 | $63K | Buy |
225
+90
| +67% | +$25.2K | 0.01% | 361 |
|
|
2022
Q1 | $35K | Buy |
135
+10
| +8% | +$2.59K | ﹤0.01% | 492 |
|
|
2021
Q4 | $27K | Sell |
125
-466
| -79% | -$101K | ﹤0.01% | 523 |
|
|
2021
Q3 | $107K | Buy |
+591
| New | +$107K | 0.01% | 294 |
|
|
2021
Q1 | – | Sell |
-44
| Closed | -$10K | – | 627 |
|
|
2020
Q4 | $10K | Buy |
+44
| New | +$10K | ﹤0.01% | 420 |
|
|
2020
Q1 | – | Sell |
-4
| Closed | -$1K | – | 573 |
|
|
2019
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 498 |
|
|
2019
Q3 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 503 |
|